VBI Vaccines Inc
F:LO9A

Watchlist Manager
VBI Vaccines Inc Logo
VBI Vaccines Inc
F:LO9A
Watchlist
Price: 0.0845 EUR Market Closed
Market Cap: 2m EUR

Relative Value

There is not enough data to reliably calculate the relative value of LO9A.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

LO9A Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
57.6
Median 5Y
56.4
Industry
7.9
Forward
0.1
vs History
vs Industry
Median 3Y
-0.8
Median 5Y
-8.2
Industry
23.7
Forward
-0
vs History
vs Industry
Median 3Y
-1.2
Median 5Y
-13.1
Industry
22
vs History
vs Industry
Median 3Y
-1.3
Median 5Y
-12.1
Industry
24.3
vs History
vs Industry
Median 3Y
5.2
Median 5Y
8
Industry
3.3
vs History
vs Industry
Median 3Y
66.7
Median 5Y
63.8
Industry
8.2
Forward
-0.9
vs History
vs Industry
Median 3Y
-10.8
Median 5Y
-93.7
Industry
10.2
vs History
vs Industry
Median 3Y
-1.6
Median 5Y
-10
Industry
6.1
vs History
vs Industry
Median 3Y
-1.5
Median 5Y
-9.7
Industry
6.5
Forward
0.3
vs History
vs Industry
Median 3Y
-1.6
Median 5Y
-12.1
Industry
7.9
vs History
vs Industry
Median 3Y
-1.5
Median 5Y
-11.6
Industry
6.3
vs History
vs Industry
Median 3Y
2
Median 5Y
7.7
Industry
5.7

Multiples Across Competitors

LO9A Competitors Multiples
VBI Vaccines Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
VBI Vaccines Inc
F:LO9A
808.8k EUR 0.1 -0 0.2 0.2
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 667 065.8 -160 014.6 -194 308.7 -192 091.4
US
Abbvie Inc
NYSE:ABBV
406.5B USD 6.8 173.1 16.7 23.7
US
Amgen Inc
NASDAQ:AMGN
179.1B USD 5 25.6 18.4 18.4
US
Gilead Sciences Inc
NASDAQ:GILD
154.9B USD 5.3 19.1 12.8 12.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
117.6B USD 10 32 23.5 24.5
US
Epizyme Inc
F:EPE
94.1B EUR 2 092.5 -534 -581.4 -565.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.7B USD 5.8 18.1 17.3 19.6
AU
CSL Ltd
ASX:CSL
83B AUD 3.6 18.6 12.6 15.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
52.8B USD 16.4 1 211.8 163.4 198.2
NL
argenx SE
XBRU:ARGX
44B EUR 14.4 33.8 58.2 59.8
P/E Multiple
Earnings Growth PEG
US
VBI Vaccines Inc
F:LO9A
Average P/E: 191.5
Negative Multiple: -0
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 014.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
173.1
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
25.6
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
19.1
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
32
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -534 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.1
10%
1.8
AU
CSL Ltd
ASX:CSL
18.6
11%
1.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 211.8
N/A N/A
NL
argenx SE
XBRU:ARGX
33.8
40%
0.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
VBI Vaccines Inc
F:LO9A
Average EV/EBITDA: 35.9
0.2
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 308.7 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.7
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
18.4
11%
1.7
US
Gilead Sciences Inc
NASDAQ:GILD
12.8
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.5
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -581.4 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.3
11%
1.6
AU
CSL Ltd
ASX:CSL
12.6
8%
1.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
163.4
N/A N/A
NL
argenx SE
XBRU:ARGX
58.2
810%
0.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
VBI Vaccines Inc
F:LO9A
Average EV/EBIT: 41.4
0.2
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -192 091.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.7
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
18.4
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.8
12%
1.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.5
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -565.9 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.6
13%
1.5
AU
CSL Ltd
ASX:CSL
15.7
11%
1.4
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
198.2
N/A N/A
NL
argenx SE
XBRU:ARGX
59.8
N/A N/A